ChemoCentryx, Inc.
Method of treating C3 glomerulopathy
Last updated:
Abstract:
Methods of treating a human suffering from or susceptible to C3 glomerulopathy comprising administering to the human an effective amount of a C5aR antagonist are provided.
Status:
Grant
Type:
Utility
Filling date:
8 Nov 2018
Issue date:
29 Mar 2022